Mixed experience - Anonymous employee GoodRx Employee Review

2.0
Dec 11, 2020
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

This company will seem great at the outset, however, by the time you hit a year mark, you’re likely it realize GoodRx has the same issues as any male and white dominated company has. Poor leadership, disconnect and miscommunication between teams, repetitive work and being asked to go above and beyond without adequate management or support. White mediocrity is celebrated while diversity is only a value on paperwork, and you’ll be asked to do work you’ll be neither supported in nor described on your original listed role expectations. You’ll slowly realize this company is a neoliberal bandage on a capitalist problem and that you and all your minority coworkers are getting lowballed while your employer can pay itself on the back for diverse hiring . HR is ignorant and useless and your manager probably hates their self and the role theyre in along with your team lead. Good luck!

Cons

Same issues you’ll encounter at literally every startup

Explore other reviews about GoodRx

5.0
May 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Great space to learn, encouraged learning from mistakes, great overall positive attitude and collaboration amongst eng and non-eng co-workers

Cons

Started to feel more of a company that started prioritizing profits and started to think of several products to ship out without much support for the reason or long term support to improve the products.

1
4.0
Jun 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Great compensation and benefits. Extreme work flexibility. Mission driven work where you know your directly helping Americans access important health care. Company is taking a great measured approach to AI adoption.

Cons

GoodRx is an established dominant player in the prescription drug space and is starting to flounder a bit in the face of stiff, more digital first, competition. Unclear what the future holds and this is reflected in the stock price. As such project direction can be a bit vague. Similarly a long history of tech debt, further muddled by HIPAA requirements, can make product development painful.

See reviews by: Helpful|Rating|Date|All